Lupin Australia arm incorporates new subsidiary in New Zealand

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2024-08-10 05:30 GMT | Update On 2024-08-10 05:30 GMT

Mumbai: Through a recent BSE filing, Lupin has informed that Generic Health Pty Ltd., Australia, a wholly owned subsidiary of the Company, has incorporated Lupin NZ Ltd., New Zealand, its wholly owned subsidiary.

Lupin NZ will be engaged in the business of pharmaceuticals and pharmaceutical devices in New Zealand.

Generic Health has subscribed to the entire issued share capital of Lupin NZ, comprising of 50000 shares of NZD 10 each aggregating NZD 500,000.

Generic Health will hold 100% shareholding in Lupin NZ.

Medical Dialogues team had earlier reported that the Company had incorporated Lupin Lanka (Private) Ltd., Sri Lanka, as wholly owned subsidiary of the Company.

Read also: Lupin Announces Positive Results from Global Phase 3 Trial of Lucentis Biosimilar

Lupin is a transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.The Company specializes in the cardiovascular, anti-diabetic, and respiratory segments and has a significant presence in the anti-infective, gastro-intestinal (GI), central nervous system (CNS), and women’s health areas. The company invested 7.8% of its revenue in research and development in FY24.Lupin has 15 manufacturing sites, 7 research centers.

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Lupin Australia arm incorporates new subsidiary in New Zealand

Similar News